Cargando…

Clinical impact and mechanisms of hepatitis B virus infection concurrent with non-alcoholic fatty liver disease

Chronic hepatitis B (CHB) virus infection is an important threat to global health despite the administration of vaccines and the use of antiviral treatments. In recent years, as the prevalence of obesity and metabolic syndrome has increased, non-alcoholic fatty liver disease (NAFLD) in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tong, Xin, Song, Yu, Yin, Shengxia, Wang, Jian, Huang, Rui, Wu, Chao, Shi, Junping, Li, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509100/ https://www.ncbi.nlm.nih.gov/pubmed/35940901 http://dx.doi.org/10.1097/CM9.0000000000002310

Ejemplares similares

Hepatitis B virus‐induced hyperactivation of B cells in chronic hepatitis B patients via TLR4
por: Li, Yang, et al.
Publicado: (2020)

Mechanism and therapeutic strategy of hepatic TM6SF2-deficient non-alcoholic fatty liver diseases via in vivo and in vitro experiments
por: Li, Zu-Yin, et al.
Publicado: (2022)

Complements are involved in alcoholic fatty liver disease, hepatitis and fibrosis
por: Lin, Cheng-Jie, et al.
Publicado: (2018)

Potential Epigenetic Mechanism in Non-Alcoholic Fatty Liver Disease
por: Sun, Chao, et al.
Publicado: (2015)

Presence of Liver Inflammation in Asian Patients With Chronic Hepatitis B With Normal ALT and Detectable HBV DNA in Absence of Liver Fibrosis
por: Liu, Jiacheng, et al.
Publicado: (2021)

Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease
por: Kawano, Yuki, et al.
Publicado: (2013)

The Accuracy and Clinical Relevance of the Multi-echo Dixon Technique for Evaluating Changes to Hepatic Steatosis in Patients with Non-alcoholic Fatty Liver Disease Treated with Formulated Food
por: Yang, Ying, et al.
Publicado: (2022)

Gamma-glutamyl Transpeptidase to Platelet Ratio Predicts Liver Injury in Hepatitis B e Antigen-negative Chronic Hepatitis B Patients With Normal Alanine Aminotransferase
por: Zhao, Xiang-An, et al.
Publicado: (2022)

Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease
por: Ipsen, David Højland, et al.
Publicado: (2018)

Molecular mechanism of alcoholic fatty liver
por: Rasineni, Karuna, et al.
Publicado: (2012)

Interaction between mucus layer and gut microbiota in non-alcoholic fatty liver disease: Soil and seeds
por: Zhang, Binbin, et al.
Publicado: (2023)

Association of Coexistent Hepatitis B Surface Antigen and Antibody With Severe Liver Fibrosis and Cirrhosis in Treatment-Naive Patients With Chronic Hepatitis B
por: Wang, Jian, et al.
Publicado: (2022)

Prognosis after hepatic resection of patients with hepatocellular carcinoma related to non-alcoholic fatty liver disease: meta-analysis
por: Su, Jia-Yong, et al.
Publicado: (2023)

An easy-to-use AIHF-nomogram to predict advanced liver fibrosis in patients with autoimmune hepatitis
por: Zhang, Zhiyi, et al.
Publicado: (2023)

The role of SAMM50 in non‐alcoholic fatty liver disease: from genetics to mechanisms
por: Li, Zuyin, et al.
Publicado: (2021)

ADAR1 Inhibits HBV DNA Replication via Regulating miR-122-5p in Palmitic Acid Treated HepG2.2.15 Cells
por: Yang, Hongli, et al.
Publicado: (2022)

A novel web-based online nomogram to predict advanced liver fibrosis in patients with autoimmune hepatitis-primary biliary cholangitis overlap syndrome
por: Zhang, Zhiyi, et al.
Publicado: (2023)

Intracellular hepatitis B virus increases hepatic cholesterol deposition in alcoholic fatty liver via hepatitis B core protein
por: Wang, Yaqi, et al.
Publicado: (2018)

Non‐alcoholic fatty liver disease in patients with autoimmune hepatitis
por: Takahashi, Atsushi, et al.
Publicado: (2018)

Challenges in the hepatic histopathology in non-alcoholic fatty liver disease
por: Brunt, Elizabeth M, et al.
Publicado: (2017)

Non-Alcoholic Fatty Liver Disease and Extra-Hepatic Cancers
por: Sanna, Claudia, et al.
Publicado: (2016)

Unravelling the Interplay: Exploring the Influence of Previous Hepatitis B Virus, Hepatitis A Virus, and Hepatitis E Virus Infections on Non-alcoholic Fatty Liver Disease
por: Narladkar, Vinay, et al.
Publicado: (2023)

The effects of PCB126 on intra-hepatic mechanisms associated with non alcoholic fatty liver disease
por: Boucher, Marie-Pier, et al.
Publicado: (2015)

Autophagy in non-alcoholic fatty liver disease and alcoholic liver disease()
por: Khambu, Bilon, et al.
Publicado: (2018)

Transient Elastography and Ultrasonography: Optimal Evaluation of Liver Fibrosis and Cirrhosis in Patients with Chronic Hepatitis B Concurrent with Nonalcoholic Fatty Liver Disease
por: Zhang, Geng-lin, et al.
Publicado: (2019)

Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection—Liver: The “Musketeer” in the Spotlight
por: Ballestri, Stefano, et al.
Publicado: (2016)

Chronic hepatitis B with concurrent metabolic dysfunction-associated fatty liver disease: Challenges and perspectives
por: Huang, Shang-Chin, et al.
Publicado: (2023)

A Novel Noninvasive Diagnostic Model of HBV-Related Inflammation in Chronic Hepatitis B Virus Infection Patients With Concurrent Nonalcoholic Fatty Liver Disease
por: Tao, Xuemei, et al.
Publicado: (2022)

Novel Ultrasonographic Fatty Liver Indicator Can Predict Hepatitis in Children With Non-alcoholic Fatty Liver Disease
por: Liu, Hsien-Kuan, et al.
Publicado: (2019)

Improvement in liver stiffness measurement for diagnosis of liver fibrosis in patients with concurrent chronic hepatitis B and nonalcoholic fatty liver disease
por: Xu, Nan, et al.
Publicado: (2020)

Validation of fatty liver index and hepatic steatosis index for screening of non-alcoholic fatty liver disease in adults with obstructive sleep apnea hypopnea syndrome
por: Chen, Li-Da, et al.
Publicado: (2019)

Homeostasis of Glucose and Lipid in Non-Alcoholic Fatty Liver Disease
por: Chao, Hsu-Wen, et al.
Publicado: (2019)

Liquid Biopsy for the Diagnosis of Viral Hepatitis, Fatty Liver Steatosis, and Alcoholic Liver Diseases
por: Shabangu, Ciniso Sylvester, et al.
Publicado: (2020)

Optimizing the Use of the Gamma-Glutamyl Transpeptidase-to-Platelet Ratio and Transient Elastography to Identify Liver Cirrhosis in Patients with Chronic Hepatitis B Concurrent with Nonalcoholic Fatty Liver Disease
por: Zhang, Geng-lin, et al.
Publicado: (2019)

B Cell-mediated Humoral Immunity in Chronic Hepatitis B Infection
por: Li, Yang, et al.
Publicado: (2021)

Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease
por: Yan, Hong-Mei, et al.
Publicado: (2015)

Establishment of the Tree Shrew as an Alcohol-Induced Fatty Liver Model for the Study of Alcoholic Liver Diseases
por: Xing, Huijie, et al.
Publicado: (2015)

Loss of Hepatic CEACAM1: A Unifying Mechanism Linking Insulin Resistance to Obesity and Non-Alcoholic Fatty Liver Disease
por: Heinrich, Garrett, et al.
Publicado: (2017)

Serum Monounsaturated Triacylglycerol Predicts Steatohepatitis in Patients with Non-alcoholic Fatty Liver Disease and Chronic Hepatitis B
por: Yang, Rui-xu, et al.
Publicado: (2017)

Betaine attenuates chronic alcohol-induced fatty liver by broadly regulating hepatic lipid metabolism
por: Yang, Wenjuan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2pj892cjakn8985d06ibvsg51s